Tag Archives: NICE

OHE report on appraising ultra-orphan drugs

The Office of Health Economics (OHE) have published a consulting report discussing the use of a cost-per-QALY gained decision rule to appraise treatments for very rare conditions. The report has been published as part of the NICE Highly Specialised Technologies (HST) programme and argues that it is inappropriate to focus a HST appraisal on only a cost-per-QALY measure and that the thresholds recommended seem arbitrary.


NICE newsletter

The National Institute for Health and Care Excellence (NICE) have issued their January newsletter. Amongst the features is an item on the use of paracetamol rather than antibiotics to relieve a sore throat and the use of an app to treat depression. There is also news of updated recommendations on the treatment and care of people with early breast cancer. Comments are invited on forthcoming guidance, including the use of community pharmacy services to promote health and wellbeing. There is also notice of the forthcoming NICE annual conference to be held in Manchester in June 2018.

NICE draft guideline on decision-making

The National Institute for Health and Care Excellence (NICE) have published draft guidance for consultation on decision making and mental capacity. The guidance aims to help health and social care practitioners support people to make their own decisions where they have the capacity to do so, and to help practitioners to keep people who lack capacity at the centre of the decision-making process. The consultation on the guideline, and economic model, is open to 5 February 2018.

NICE ruling on mesh repairs

The National Institute for Health and Care Excellence (NICE) have issued guidance confirming that transvaginal mesh repair of anterior or posterior vaginal wall prolapse should only be performed in the context of research. The guidance is published under the Interventional Procedures Programme. It is obligatory for NHSScotland to follow NICE Interventional Procedures Programme guidance.

NICE newsletter

The latest National Institute for Health and Care Excellence (NICE) newsletter highlights  draft guidance on developmental check-ups on children born pre-term, and guidance on new tests to diagnose asthma and a change in how asthma medicines are offered. There is also news on self-help for eating disorders and a decision that the drug lenvatinib should be available for people with advanced kidney cancer.


The National Institute for Health and Care Excellence (NICE) has launched the Preliminary Independent Model Advice (PRIMA) service to ‘health-check’ economic models. PRIMA is a fee-based consultancy service offering a detailed peer review service to help developers of drugs, medical devices and diagnostics, and public health interventions ensure the quality of their model structure, coding, usability and transparency.